EUVIMEDEUVIMED entdecken
Crossref

An interpretable survival benefit analytics framework for optimizing cancer treatment decision-making

Shuchao Chen, Haojiang Li, Hui Mao, Tianhe Wu, Chao Luo, Zhiying Liang, Shanshan Liu, Yifei Liu, Haoyang Zhou, Lizhi Liu, Hongbo Chen

Medical & Biological Engineering & Computing · 2026-06 · 64 (6) · 2269-2285

DOI: 10.1007/s11517-026-03586-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical & Biological Engineering & Computing, online erschienen am 02.05.2026. Verfasst von Shuchao Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China. Hauptthemen laut MEDLINE: Neoplasms, Decision Making. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Optimal treatment decision-making is critical to the long-term survival rate of patients in clinical management of cancer. Traditional treatment decision-making models typically reach treatment decisions indirectly by estimating the various risks to the beneficial outcome of patients, which limits the interpretability of treatment effects and the performance of the models. We propose SurvS(survival supervision), a novel interpretable survival benefit analytics framework based on the real-coded genetic algorithm, to integrate individual treatment effects that directly impact long-term survival benefits. SurvS can not only construct binary (beneficial and nonbeneficial), but also construct ternary (beneficial, insensitive, and detrimental) decision-making models, allowing the identification of all three possible outcomes in a single model. The framework generates personalized model scores by integrating weighted clinical features and real-valued cutoff thresholds, optimized to reflect survival outcome differences. The robust performances of SurvS were demonstrated in decision-making tasks of two clinical cancer treatment scenarios: induction chemotherapy for nasopharyngeal carcinoma and adjuvant chemotherapy for rectal cancer. SurvS outperformed traditional methods and maintained robust performance in the independent validation cohort. By enabling survival benefit-supervised optimization and interpretable model construction, reported SurvS offers a powerful tool for personalized cancer treatment planning with the potential to improve treatment efficacy and reduce overtreatment. The code is open source and available at: https://github.com/odindis/SurvS .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDecision MakingHumansAlgorithmsGenetic AlgorithmsSurvival AnalysisNasopharyngeal NeoplasmsNasopharyngeal CarcinomaRectal Neoplasms

Stichwörter der Autor:innen

CancerIndividual treatment effectReal-coded genetic algorithmSurvival benefit analysisTreatment decision-making

Autor:innen und Institutionen

  • School of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China.
  • State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Department of Radiology and Imaging Science and Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
  • School of Life & Environmental Science, Guilin University of Electronic Technology, Guilin, 541004, China. hongbochen@163.com.
  • Guangxi Human Physiological Information Non-Invasive Detection Engineering Technology Research Center, Guilin, 541004, China. hongbochen@163.com.

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China

Zitieren

APA

Chen, S., Li, H., Mao, H., Wu, T., Luo, C., Liang, Z., Liu, S., Liu, Y., Zhou, H., Liu, L., & Chen, H. (2026). An interpretable survival benefit analytics framework for optimizing cancer treatment decision-making. Medical & Biological Engineering & Computing, 64(6), 2269-2285. https://doi.org/10.1007/s11517-026-03586-0

Vancouver

Chen S, Li H, Mao H, Wu T, Luo C, Liang Z, et al. An interpretable survival benefit analytics framework for optimizing cancer treatment decision-making. Medical & Biological Engineering & Computing. 2026;64(6):2269-2285. doi:10.1007/s11517-026-03586-0

BibTeX
@article{Chen2026,
  author = {Chen, Shuchao and Li, Haojiang and Mao, Hui and Wu, Tianhe and Luo, Chao and Liang, Zhiying and Liu, Shanshan and Liu, Yifei and Zhou, Haoyang and Liu, Lizhi and Chen, Hongbo},
  title = {An interpretable survival benefit analytics framework for optimizing cancer treatment decision-making},
  journal = {Medical & Biological Engineering & Computing},
  year = {2026},
  volume = {64},
  number = {6},
  pages = {2269--2285},
  doi = {10.1007/s11517-026-03586-0}
}
Kostenlos starten →